JP2006511620A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511620A5 JP2006511620A5 JP2005508486A JP2005508486A JP2006511620A5 JP 2006511620 A5 JP2006511620 A5 JP 2006511620A5 JP 2005508486 A JP2005508486 A JP 2005508486A JP 2005508486 A JP2005508486 A JP 2005508486A JP 2006511620 A5 JP2006511620 A5 JP 2006511620A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical formulation
- preparation according
- pharmaceutical
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 14
- 239000000825 pharmaceutical preparation Substances 0.000 claims 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 229950004393 visilizumab Drugs 0.000 claims 4
- 206010009900 Colitis ulcerative Diseases 0.000 claims 3
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims 2
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 claims 2
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 claims 2
- 229960004963 mesalazine Drugs 0.000 claims 2
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 claims 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 claims 1
- 229960000890 hydrocortisone Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 229960001428 mercaptopurine Drugs 0.000 claims 1
- 229960004584 methylprednisolone Drugs 0.000 claims 1
- 229960005343 ondansetron Drugs 0.000 claims 1
- 229960005489 paracetamol Drugs 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43164902P | 2002-12-05 | 2002-12-05 | |
| US45018303P | 2003-02-25 | 2003-02-25 | |
| PCT/US2003/038809 WO2004052397A1 (en) | 2002-12-05 | 2003-12-05 | Methods of treatment of ulcerative colitis with anti-cd3 antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006511620A JP2006511620A (ja) | 2006-04-06 |
| JP2006511620A5 true JP2006511620A5 (https=) | 2007-01-25 |
Family
ID=32511592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005508486A Pending JP2006511620A (ja) | 2002-12-05 | 2003-12-05 | 抗ｃｄ３抗体による潰瘍性大腸炎の処置方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20040253237A1 (https=) |
| EP (1) | EP1567192A4 (https=) |
| JP (1) | JP2006511620A (https=) |
| KR (1) | KR20050091713A (https=) |
| AU (1) | AU2003298015A1 (https=) |
| CA (1) | CA2508264A1 (https=) |
| WO (1) | WO2004052397A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1687066T3 (da) | 2003-11-14 | 2012-11-26 | Brigham & Womens Hospital | Fremgangsmåder til immunmodulering |
| JP5139800B2 (ja) | 2004-06-03 | 2013-02-06 | ノビミューン エスアー | 抗ｃｄ３抗体およびその使用方法 |
| WO2007026742A1 (ja) * | 2005-08-30 | 2007-03-08 | Ajinomoto Co., Inc. | 大腸デリバリー型炎症性大腸疾患治療薬 |
| AR057807A1 (es) * | 2005-09-12 | 2007-12-19 | Novimmune Sa | Formulaciones de anticuerpo anti-cd3 |
| AU2012201443B2 (en) * | 2006-06-06 | 2014-04-03 | Glaxo Group Limited | Administration of anti-CD3 antibodies in the treatment of autoimmune diseases |
| JP2009539841A (ja) * | 2006-06-06 | 2009-11-19 | トラークス，インコーポレイテッド | 自己免疫疾患の治療における抗ｃｄ３抗体の投与 |
| RS67768B1 (sr) | 2010-11-30 | 2026-03-31 | Chugai Pharmaceutical Co Ltd | Terapijski agens koji indukuje citotoksičnost |
| US11702477B2 (en) | 2015-11-06 | 2023-07-18 | Orionis Biosciences BV | Bi-functional chimeric proteins and uses thereof |
| US11001631B2 (en) | 2016-02-05 | 2021-05-11 | Orionis Biosciences BV | Clec9A binding agents |
| KR102379464B1 (ko) | 2016-06-20 | 2022-03-29 | 키맵 리미티드 | 항-pd-l1 항체 |
| US10610104B2 (en) | 2016-12-07 | 2020-04-07 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| CN110573172A (zh) | 2017-02-06 | 2019-12-13 | 奥里尼斯生物科学有限公司 | 靶向的工程化干扰素及其用途 |
| US20210138213A1 (en) * | 2017-03-30 | 2021-05-13 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| WO2019246312A1 (en) | 2018-06-20 | 2019-12-26 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunomodulator |
| US12227565B2 (en) | 2018-06-20 | 2025-02-18 | Biora Therapeutics, Inc. | Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine |
| US20220249814A1 (en) | 2018-11-19 | 2022-08-11 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
| CN121197633A (zh) | 2019-12-13 | 2025-12-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| CN118562007A (zh) * | 2019-12-19 | 2024-08-30 | 苏州方德门达新药开发有限公司 | 工程改造的t细胞、其制备及应用 |
| CN119095873A (zh) | 2022-03-14 | 2024-12-06 | 拉姆卡普生物伽马股份公司 | 用于靶向杀伤GPC3阳性恶性细胞的双特异性GPC3xCD28和GPC3xCD3抗体及其组合 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5932214A (en) * | 1994-08-11 | 1999-08-03 | Biogen, Inc. | Treatment for inflammatory bowel disease with VLA-4 blockers |
| US5834597A (en) * | 1996-05-20 | 1998-11-10 | Protein Design Labs, Inc. | Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same |
| DE19905012A1 (de) * | 1999-02-08 | 2000-08-10 | Gsf Forschungszentrum Umwelt | Arzneimittel enthaltend Anti-CD3- und Anti-Fcgamma-R-Antikörper zur begleitenden Behandlung bei Organtransplantationen |
| US20040219142A1 (en) * | 2002-07-19 | 2004-11-04 | Abbott Laboratories S.A. | Treatment of skin and nail disorders using TNFalpha inhibitors |
-
2003
- 2003-12-05 CA CA002508264A patent/CA2508264A1/en not_active Abandoned
- 2003-12-05 AU AU2003298015A patent/AU2003298015A1/en not_active Abandoned
- 2003-12-05 EP EP03796736A patent/EP1567192A4/en not_active Withdrawn
- 2003-12-05 KR KR1020057010239A patent/KR20050091713A/ko not_active Withdrawn
- 2003-12-05 US US10/729,795 patent/US20040253237A1/en not_active Abandoned
- 2003-12-05 JP JP2005508486A patent/JP2006511620A/ja active Pending
- 2003-12-05 WO PCT/US2003/038809 patent/WO2004052397A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511620A5 (https=) | ||
| JP7293122B2 (ja) | 補体が媒介する疾患および障害を処置するための方法 | |
| TWI306458B (en) | Humanized antibodies that recognize beta amyloid peptide | |
| CN111068062B (zh) | 治疗白介素-6相关疾病的方法 | |
| JP2020536888A5 (https=) | ||
| JP2020537644A5 (https=) | ||
| JP2021502961A5 (https=) | ||
| JP2014114288A5 (https=) | ||
| JP2025183307A5 (https=) | ||
| JPWO2020059847A5 (https=) | ||
| JP2021531255A (ja) | 非古典的ｈｌａ−ｉおよびネオアンチゲンを含む複合体を標的とする抗体、およびその使用方法 | |
| JPWO2020018922A5 (https=) | ||
| JP2013519690A5 (https=) | ||
| EP3634478A1 (en) | Methods of suppressing microglial activation | |
| US20240109977A1 (en) | Anti-cd38 antibodies and their uses | |
| US20230227555A1 (en) | Cd-3 antibodies for the treatment of coronavirus | |
| JP2024507986A (ja) | 抗体関連型移植拒絶反応の治療に使用するための抗ｃｄ３８抗体 | |
| CN116635422A (zh) | 抗cd38抗体及其用途 | |
| JPWO2020079086A5 (https=) | ||
| JPWO2020215019A5 (https=) | ||
| JP2019519470A5 (https=) | ||
| JPWO2021171002A5 (https=) | ||
| JPWO2022099257A5 (https=) | ||
| JPWO2023079485A5 (https=) | ||
| NZ749153A9 (en) | Anti-c5 antibodies and uses thereof |